更正：正电子发射断层扫描对恶性肿瘤中免疫检查点抑制剂（ICIs）预后的预测价值。
Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.
作者信息
Wu Qing, Liu Junjin, Zhang Yanhong, Wu Sumei, Xie Xianhe
机构信息
Department of Oncology, The First Affiliated Hospital of Fujian Medical University, Chazhong Road No. 20, Fuzhou, 350005, Fujian, China.
出版信息
Cancer Immunol Immunother. 2020 Jun;69(6):937. doi: 10.1007/s00262-020-02541-8.
Abstract
The original version of this article unfortunately contained a mistake. The correct information is given in the following.
摘要
很遗憾，本文的原始版本存在一处错误。以下是正确信息。
相似文献
1
Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.更正：正电子发射断层扫描对恶性肿瘤中免疫检查点抑制剂（ICIs）预后的预测价值。
Cancer Immunol Immunother. 2020 Jun;69(6):937. doi: 10.1007/s00262-020-02541-8.
2
Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.正电子发射断层扫描预测恶性肿瘤免疫检查点抑制剂（ICIs）的预后价值。
Cancer Immunol Immunother. 2020 Jun;69(6):927-936. doi: 10.1007/s00262-020-02515-w. Epub 2020 Feb 19.
3
Correction to: Expression of the immune checkpoint VISTA in breast cancer.对《乳腺癌中免疫检查点VISTA的表达》的更正
Cancer Immunol Immunother. 2020 Aug;69(8):1447. doi: 10.1007/s00262-020-02602-y.
4
[Advances in predictive biomarkers associated with immune checkpoint inhibitors for tumor therapy].[肿瘤治疗中与免疫检查点抑制剂相关的预测生物标志物的进展]
Sheng Wu Gong Cheng Xue Bao. 2023 Apr 25;39(4):1403-1424. doi: 10.13345/j.cjb.220650.
5
Correction to: Strategies for Predicting Response to Checkpoint Inhibitors.对《预测免疫检查点抑制剂反应的策略》的更正
Curr Hematol Malig Rep. 2019 Feb;14(1):62. doi: 10.1007/s11899-018-0488-0.
6
PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy.正电子发射断层扫描/计算机断层扫描（PET/CT）分子成像在免疫检查点抑制剂治疗时代。
Front Immunol. 2022 Oct 20;13:1049043. doi: 10.3389/fimmu.2022.1049043. eCollection 2022.
7
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.免疫检查点抑制剂免疫疗法与恶性间皮瘤的预测生物标志物：仍在进行中的工作。
Front Immunol. 2023 Jan 27;14:1121557. doi: 10.3389/fimmu.2023.1121557. eCollection 2023.
8
Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.癌症进展期患者接受免疫检查点抑制剂治疗的肌肉减少症及其预后：全面系统评价和荟萃分析。
Nutrition. 2021 Oct;90:111345. doi: 10.1016/j.nut.2021.111345. Epub 2021 May 21.
9
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors.接受免疫检查点抑制剂治疗的癌症患者发生血栓栓塞的危险因素、发病率及预后
Front Pharmacol. 2021 Nov 8;12:747075. doi: 10.3389/fphar.2021.747075. eCollection 2021.
10
Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy.正电子发射断层扫描分子成像监测免疫检查点抑制剂治疗的抗肿瘤全身反应。
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1671-1688. doi: 10.1007/s00259-022-06084-1. Epub 2023 Jan 9.
Zotero 插件